Stocks News

LAST PRICE
75.7700
TODAY'S CHANGE (%)
Trending Down-0.8600 (-1.1223%)

Bid / Lots
74.2500/ 10
Ask / Lots
77.3900/ 1
Open / Previous Close
76.3600 / 76.6300
Day Range
Low 75.6200
High 76.5100
52 Week Range
Low 64.0200
High 87.8800
Volume
1,512,438
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Hologic to Acquire Breast Cancer Surgery Technology Firm Endomagnetics For $310 Million, from 22 hours ago by MT Newswires
  22 hours ago by MT Newswires
  Companies Mentioned: HOLX
  05:58 PM EDT, 04/29/2024 (MT Newswires) -- Hologic (HOLX) said late Monday it agreed to acquire Endomagnetics for about $310 million. UK-based Endomagnetics develops and sells breast surgery localization and lymphatic tracing technologies. Hologic s...
- Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company, from 4:05PM ET on Monday Apr 29, 2024 by Dow Jones
  4:05PM ET on Monday Apr 29, 2024 by Dow Jones
  Companies Mentioned: HOLX
  MARLBOROUGH, Mass.--(BUSINESS WIRE)--April 29, 2024--
  Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag(R)), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital and other customary closing adjustments.
- *DJ Hologic To Acquire Endomagnetics Ltd, A Breast Surgical Guidance Company >HOLX, from 4:05PM ET on Monday Apr 29, 2024 by Dow Jones
  4:05PM ET on Monday Apr 29, 2024 by Dow Jones
  Companies Mentioned: HOLX
  
  Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company
  MARLBOROUGH, Mass.--(BUSINESS WIRE)--April 29, 2024--
  Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag(R)), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital and other customary closing adjustments.
Apr 10, 2024
- DJ Hologic Price Target Maintained With a $90.00/Share by Needham, from 5:29AM ET on Wednesday Apr 10, 2024 by Dow Jones
  5:29AM ET on Wednesday Apr 10, 2024 by Dow Jones
  Companies Mentioned: HOLX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HOLX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 10, 2024 05:29 ET (09:29 GMT)
Apr 8, 2024
- RBC Raises Price Target on Hologic to $81 From $76, Keeps Sector Perform Rating, from 7:48AM ET on Monday Apr 08, 2024 by MT Newswires
  7:48AM ET on Monday Apr 08, 2024 by MT Newswires
  Companies Mentioned: HOLX
  07:48 AM EDT, 04/08/2024 (MT Newswires) -- Hologic (HOLX) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $70 to $95. (MT Newswires covers equity, commodity and economic research f...

Today
- TD Cowen Adjusts Price Target on Revvity to $130 From $123, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: RVTY
- --JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained, from 8 hours ago by MT Newswires
  8 hours ago by MT Newswires
  Companies Mentioned: RVTY
- Baird Adjusts Price Target on Revvity to $127 From $126, from 9 hours ago by MT Newswires
  9 hours ago by MT Newswires
  Companies Mentioned: RVTY
- Bernstein Adjusts Price Target on Revvity to $123 From $125, Keeps Outperform Rating, from 10 hours ago by MT Newswires
  10 hours ago by MT Newswires
  Companies Mentioned: RVTY
Yesterday
- Nephron Adjusts Revvity's Price Target to $124 From $120, from 9:51AM ET on Monday Apr 29, 2024 by MT Newswires
  9:51AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: RVTY
- Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday, from 9:02AM ET on Monday Apr 29, 2024 by MT Newswires
  9:02AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: IBB, PHG, RVTY, XLV, DCPH
- Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance, from 7:22AM ET on Monday Apr 29, 2024 by MT Newswires
  7:22AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: RVTY
- -- Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, vs. Street Est of $647.5M, from 6:01AM ET on Monday Apr 29, 2024 by MT Newswires
  6:01AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: RVTY
- -- Earnings Flash (RVTY) REVVITY Posts Q1 EPS $0.98, vs. Street Est of $0.94, from 6:00AM ET on Monday Apr 29, 2024 by MT Newswires
  6:00AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: RVTY
Apr 26, 2024
- Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference, from 7:00AM ET on Friday Apr 26, 2024 by Business Wire
  7:00AM ET on Friday Apr 26, 2024 by Business Wire
  Companies Mentioned: BRKR

Hologic Inc
NASDAQ:HOLXUnited States

Search Criteria

Yesterday

Hologic to Acquire Breast Cancer Surgery Technology Firm Endomagnetics For $310 Million, from 22 hours ago by MT Newswires

Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company, from 4:05PM ET on Monday Apr 29, 2024 by Dow Jones

*DJ Hologic To Acquire Endomagnetics Ltd, A Breast Surgical Guidance Company >HOLX, from 4:05PM ET on Monday Apr 29, 2024 by Dow Jones

Apr 10, 2024

DJ Hologic Price Target Maintained With a $90.00/Share by Needham, from 5:29AM ET on Wednesday Apr 10, 2024 by Dow Jones

Apr 8, 2024

RBC Raises Price Target on Hologic to $81 From $76, Keeps Sector Perform Rating, from 7:48AM ET on Monday Apr 08, 2024 by MT Newswires

Peers Headlines

Today

TD Cowen Adjusts Price Target on Revvity to $130 From $123, from 7 hours ago by MT Newswires

--JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained, from 8 hours ago by MT Newswires

Baird Adjusts Price Target on Revvity to $127 From $126, from 9 hours ago by MT Newswires

Bernstein Adjusts Price Target on Revvity to $123 From $125, Keeps Outperform Rating, from 10 hours ago by MT Newswires

Yesterday

Nephron Adjusts Revvity's Price Target to $124 From $120, from 9:51AM ET on Monday Apr 29, 2024 by MT Newswires

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday, from 9:02AM ET on Monday Apr 29, 2024 by MT Newswires

Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance, from 7:22AM ET on Monday Apr 29, 2024 by MT Newswires

-- Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, vs. Street Est of $647.5M, from 6:01AM ET on Monday Apr 29, 2024 by MT Newswires

-- Earnings Flash (RVTY) REVVITY Posts Q1 EPS $0.98, vs. Street Est of $0.94, from 6:00AM ET on Monday Apr 29, 2024 by MT Newswires

Apr 26, 2024

Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference, from 7:00AM ET on Friday Apr 26, 2024 by Business Wire